Poster Session I - A162 COLON-SPECIFIC MINIMALLY INVASIVE ENDOSCOPIC RESECTION OUTCOMES: A PROSPECTIVE MULTICENTER COHORT OF 1000 LARGE NON-PEDUNCULATED COLONIC POLYPS

TL;DR

This study shows that endoscopic resection of large non-pedunculated colon polyps in a Canadian program is highly effective and safe.

Contribution

The paper presents the first large Canadian multicenter data on outcomes of endoscopic resection for large non-pedunculated colonic polyps.

Findings

Technical success was achieved in 98.3% of cases.

Adverse events were low, with 3.0% intraprocedural perforation and 4.7% clinically significant post-endoscopic resection bleeding.

Recurrence at first surveillance colonoscopy was 2.3%.

Abstract

Endoscopic resection has revolutionized the management of large (≥ 20 mm) non-pedunculated colonic polyps (LNPCPs) with international data demonstrating its efficacy, safety and cost-effectiveness. Canadian outcome data from tertiary resection programs remains limited

Evaluate the outcomes of endoscopic resection of LNPCPs in a Canadian tertiary referral program.

Consecutive adult patients referred for the management of a LNPCP were enrolled in a prospective multi-centre cohort (ClinicalTrials.gov identifier: NCT05402696). Endoscopic modality selection (endoscopic mucosal resection [EMR], cold snare resection [CSR], or endoscopic submucosal dissection [ESD]) was at the discretion of the endoscopist. The primary outcome was technical success (removal of all polypoid tissue at index resection). Secondary outcomes included peri-procedural adverse events (intra-procedural perforation [IPP], clinically significant post-endoscopic resection bleeding [CSPEB], delayed perforation), and recurrence at first surveillance colonoscopy (SC1).

From 06/2022 – 10/2025, 1138 large colorectal lesions were enrolled; 38 did not undergo endoscopic resection and 97 were located in the rectum. Ultimately 1003 LNPCPs were included for analysis. Median patient age was 68 years (IQR 61-73 years), and 45.4% of patients were female. Median lesion size was 25 mm (IQR 20-35mm) with 46.9% located in the cecum/ascending colon. The predominant morphology was Paris 0-IIA (66.1%) with 44.8% demonstrating granular topography. On histopathology, 62.5% were adenomas and 30.6% were sessile serrated lesions. Overall cancer frequency was 3.4%. Predominant resection modalities included piecemeal EMR (55.4%), CSR (26.3%), and ESD (9.5%). Technical success was achieved in 98.3%. Intraprocedural perforation occurred in 3.0% and CSPEB occurred in 4.7% with no delayed perforations. Hospital admission was required in 7.5% of patients, primarily due to CSPEB. Recurrence at SC1 was identified in 2.3%.

Our findings support that tertiary tissue resection programs demonstrate high performance in minimally invasive endoscopic resection for LNPCPs.

None